Results 21 to 30 of about 58,795 (276)

European Society of Gynaecological Oncology guidelines for the peri-operative management of advanced ovarian cancer patients undergoing debulking surgery

open access: yesInternational Journal of Gynecological Cancer, 2021
The European Society of Gynaecological Oncology (ESGO) developed and established for the first time in 2016, and updated in 2020, quality indicators for advanced ovarian cancer surgery to audit and improve clinical practice in Europe and beyond.
C. Fotopoulou   +18 more
semanticscholar   +1 more source

Salvage Hepatectomy for Giant GIST Liver Metastases Unresponsive to Systemic Therapy—Case Report

open access: yesLife, 2023
Therapeutic decision-making for advanced GIST liver metastases is challenging due to limited clinical evidence. This case study aims to demonstrate the survival benefit of resection in non-responsive cases.
Alin Kraft   +7 more
doaj   +1 more source

Edematous Dermal Thickening on Magnetic Resonance Imaging as a Biomarker for Lymphatic Surgical Outcomes

open access: yesMedicina, 2023
Background and Objectives: One of the surgical treatments for breast cancer-related lymphedema (BCRL) is debulking lipectomy. The aim of this study is to investigate whether dermal thickness could be utilized as an objective indicator of post-operative ...
JacqueLyn R. Kinney   +6 more
doaj   +1 more source

Neoadjuvant chemotherapy versus debulking surgery in advanced tubo-ovarian cancers: pooled analysis of individual patient data from the EORTC 55971 and CHORUS trials. [PDF]

open access: yesThe Lancet Oncology, 2018
Background: Individual patient data from two randomised trials comparing neoadjuvant chemotherapy with upfront debulking surgery in advanced tubo-ovarian cancer were analysed to examine long-term outcomes for patients and to identify any preferable ...
I. Vergote   +18 more
semanticscholar   +6 more sources

Debulking surgery for malignant tumors: the current status, evidence and future perspectives.

open access: yesJapanese Journal of Clinical Oncology, 2021
Debulking surgery, also called cytoreductive surgery, is a resection of the tumor as much as possible and an intended incomplete resection for unresectable malignant tumors. Since the most important principle in surgical oncology is complete R0 resection,
T. Hishida   +4 more
semanticscholar   +1 more source

Localized orbital amyloidosis – A varied presentation

open access: yesOman Journal of Ophthalmology, 2022
Localized orbital amyloidosis is rare, usually slowly progressive and benign disorder. The most common signs and symptoms include visible periocular mass, ptosis, proptosis, globe displacement, ocular motility disturbances, recurrent periocular ...
Akila V Ramkumar   +3 more
doaj   +1 more source

Impact of residual disease at interval debulking surgery on platinum resistance and patterns of recurrence for advanced-stage ovarian cancer

open access: yesInternational Journal of Gynecological Cancer, 2021
Objective To evaluate the impact of size and distribution of residual disease after interval debulking surgery on the timing and patterns of recurrence for patients with advanced-stage epithelial ovarian cancer.
A. Greer   +9 more
semanticscholar   +1 more source

Interval between debulking surgery and adjuvant chemotherapy is associated with overall survival in patients with advanced ovarian cancer. [PDF]

open access: greenGynecologic Oncology, 2018
M. Timmermans   +6 more
semanticscholar   +2 more sources

Primary or Interval Debulking Surgery for Advanced Endometrial Cancer with Carcinosis: A Systematic Review and Individual Patient Data Meta-Analysis of Survival Outcomes. [PDF]

open access: yesCancers (Basel)
Objective: To compare the survival outcomes of primary debulking surgery and platinum-based adjuvant chemotherapy versus interval debulking surgery after platinum-based neoadjuvant chemotherapy in patients with stage IVb endometrial cancer and peritoneal
Mantovani G   +9 more
europepmc   +3 more sources

Muscle loss during primary debulking surgery and chemotherapy predicts poor survival in advanced‐stage ovarian cancer

open access: yesJournal of Cachexia, Sarcopenia and Muscle, 2020
Sarcopenia is commonly observed in patients with advanced‐stage epithelial ovarian cancer (EOC). However, the effect of body composition changes—during primary debulking surgery (PDS) and adjuvant platinum‐based chemotherapy—on outcomes of patients with ...
Chueh-Yi Huang   +8 more
semanticscholar   +1 more source

Home - About - Disclaimer - Privacy